EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 30, 2014, Pages 11157-11162

  Qiu, Jin ^a   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EBV miRNA; MAPK pathway; Viral reactivation

Indexed keywords

BART 18-5P; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; UNCLASSIFIED DRUG; VIRUS RNA;

3' UNTRANSLATED REGION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS INHIBITION; VIRUS REPLICATION;

EBV MIRNA; MAPK PATHWAY; VIRAL REACTIVATION;

3' UNTRANSLATED REGIONS; CELL LINE, TRANSFORMED; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICRORNAS; RNA, VIRAL; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84904974858     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1406136111     Document Type: Article

References (37)

1. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA (1998) EBV persistence in memory B cells in vivo. Immunity 9(3):395-404. (Pubitemid 28462760)
2. Thorley-Lawson DA (2001) Epstein-Barr virus: Exploiting the immune system. Nat Rev Immunol 1(1):75-82.
3. Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA (1999) Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med 190(4):567-576. (Pubitemid 29395384)
4. Kieff E, Rickinson AB (2007) Epstein-Barr virus and its replication. Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), 5th Ed, Vol 2, pp 2603-2654.
5. Laichalk LL, Thorley-Lawson DA (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79(2):1296-1307. (Pubitemid 40053911)
6. Thorley-Lawson DA, Edson CM (1979) Polypeptides of the Epstein-Barr virus membrane antigen complex. J Virol 32(2):458-467. (Pubitemid 10188760)
7. Thorley-Lawson DA, Geilinger K (1980) Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci USA 77(9):5307-5311. (Pubitemid 11195555)
8. Klinke O, Feederle R, Delecluse HJ (2014) Genetics of Epstein-Barr virus microRNAs. Semin Cancer Biol 26C:52-59.
9. Kempkes B, Pich D, Zeidler R, Sugden B, HammerschmidtW (1995) Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. J Virol 69(1):231-238. (Pubitemid 24378798)
10. Qiu J, et al. (2011) A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 7(8):e1002193.
11. Li X, et al. (2010) Tpl2/AP-1 enhances murine gammaherpesvirus 68 lytic replication. J Virol 84(4):1881-1890.
12. Pan H, Xie J, Ye F, Gao SJ (2006) Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection. J Virol 80(11):5371-5382.
13. Adamson AL, et al. (2000) Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J Virol 74(3):1224-1233. (Pubitemid 30044071)
14. Satoh T, Hoshikawa Y, Satoh Y, KurataT, Sairenji T (1999) The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells. Virus Genes 18(1):57-64. (Pubitemid 29137491)
15. Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ (2008) Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogena-ctivated protein kinase pathways. Virology 371(1):139-154.
16. Stahl JA, et al. (2013) Phosphoproteomic analyses reveal signaling pathways that facilitate lytic gammaherpesvirus replication. PLoS Pathog 9(9):e1003583.
17. Yuan J, Cahir-McFarland E, Zhao B, Kieff E (2006) Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol 80(5):2548-2565. (Pubitemid 43271560)
18. Gao X, Ikuta K, Tajima M, Sairenji T (2001) 12-O-tetradecanoylphorbol-13- acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase. Virology 286(1):91-99. (Pubitemid 32675469)
19. Kim H, et al. (2010) Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad Sci USA 107(5):2183-2188.
20. Ghosh Z, Mallick B, Chakrabarti J (2009) Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res 37(4):1035-1048.
21. Gottwein E, et al. (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature 450(7172):1096- 1099.
22. Kincaid RP, Sullivan CS (2012) Virus-encoded microRNAs: An overview and a look to the future. PLoS Pathog 8(12):e1003018.
23. Countryman J, Miller G (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 82(12):4085-4089. (Pubitemid 15052833)
24. Schonteich E, et al. (2008) The Rip11/Rab11-FIP5 and kinesin II complex regulates endocytic protein recycling. J Cell Sci 121(Pt 22):3824-3833.
25. Matsunaga K, et al. (2009) Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 11(4):385-396.
26. Sir D, Ou JH (2010) Autophagy in viral replication and pathogenesis. Mol Cells 29(1):1-7.
27. Cavignac Y, Esclatine A (2010) Herpesviruses and autophagy: Catch me if you can! Viruses 2(1):314-333.
28. Irie T, Nagata N, Yoshida T, Sakaguchi T (2008) Recruitment of Alix/AIP1 to the plasma membrane by Sendai virus C protein facilitates budding of virus-like particles. Virology 371(1):108-120.
29. Strack B, Calistri A, Craig S, Popova E, Göttlinger HG (2003) AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114(6):689-699. (Pubitemid 37186765)
30. Shtanko O, Watanabe S, Jasenosky LD, Watanabe T, Kawaoka Y (2011) ALIX/AIP1 is required for NP incorporation into Mopeia virus Z-induced virus-like particles. J Virol 85(7):3631-3641.
31. Watanabe T, et al. (2007) Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci USA 104(24):10205-10210. (Pubitemid 47175287)
32. Cristea IM, et al. (2010) Host factors associated with the Sindbis virus RNA-dependent RNA polymerase: Role for G3BP1 and G3BP2 in virus replication. J Virol 84(13):6720-6732.
33. Blackford AN, et al. (2008) A role for E1B-AP5 in ATR signaling pathways during adenovirus infection. J Virol 82(15):7640-7652. (Pubitemid 352031230)
34. Rickinson AB, Kieff E (2007) Epstein-Barr virus. Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, New York), 5th Ed, Vol 2, pp 2655-2700.
35. Hochberg D, et al. (2004) Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci USA 101(1):239-244. (Pubitemid 38084234)
36. Zuo J, et al. (2011) The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. J Virol 85(4):1604-1614.
37. Decker LL, Klaman LD, Thorley-Lawson DA (1996) Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol 70(5):3286-3289. (Pubitemid 26121950)